Chen Sophie S, Corteling Randolph, Stevanato Lara, Sinden John
Department of Research and Development, Ovarian and Prostate Cancer Research Trust Laboratory, Guildford, Surrey GU2 7YG, United Kingdom.
Discov Med. 2012 Nov;14(78):327-33.
Metastasis is one of the cancer hallmarks described by Hanahan and Weinberg. Emerging evidence shows that it requires interplays between cancer cells and micro-environmental biofactors. Indoleamine 3,5-dioxygenase-1 (IDO-1) produced by cancer, local lymph nodes, and satellite cells have been demonstrated as one of the biofactors. Aberrant IDO-1 activity has partially contributed to immunosuppressive environment by repressing T lymphocyte and natural killer cell activities, and activating regulatory T cells (Treg, CD4+CD25+). Clinical investigations further show a negative correlation between the enzyme activity and prognosis in patients with various cancer types. The findings suggest a possible role of IDO-1 inhibitor in restoring host anti-tumor immunity and attenuating cancer metastasis. Data from preclinical and phase I/II clinical studies with IDO-1 inhibitors support this hypothesis. Polyphenols as antioxidants are shown to exhibit anticancer activities. However, the underlying mechanism has not been entirely characterized. We recently found that certain flavone molecules profoundly inhibit the enzymatic activity of IDO-1 but not mRNA expression in human neuronal stem cells (hNSC) confirmed by cell-based assay and qRT-PCR. To further the investigation, we studied additional anti-cancer phytochemicals including chalcone, flavonol, isoflavone, and diterpene. Here we summarize the results and show that the inhibitory sensitivity depends on the molecular structure in the following order: apigenin > wogonin > chrysin > biacalein ~ genistein > quercetin. Curcumin and isoliquiritigenin (a chalcone) exhibited toxicity to hNSCs. Although oridonin (a diterpene) showed a null toxicity toward hNSCs, it repressed the enzymatic function only marginally in contrast to its potent cytotoxicity in various cancer cell lines. While the mode of action of the enzyme-polyphenol complex awaits to be investigated, the sensitivity of enzyme inhibition was compared to the anti-proliferative activities toward three cancer cell lines. The IC50s obtained from both sets of the experiments indicate that they are in the vicinity of micromolar concentration with the enzyme inhibition slightly more active. These results suggest that attenuation of immune suppression via inhibition of IDO-1 enzyme activity may be one of the important mechanisms of polyphenols in chemoprevention or combinatorial cancer therapy.
转移是Hanahan和Weinberg所描述的癌症特征之一。新出现的证据表明,它需要癌细胞与微环境生物因子之间的相互作用。癌症、局部淋巴结和卫星细胞产生的吲哚胺3,5-双加氧酶-1(IDO-1)已被证明是其中一种生物因子。异常的IDO-1活性通过抑制T淋巴细胞和自然杀伤细胞的活性以及激活调节性T细胞(Treg,CD4+CD25+),部分促成了免疫抑制环境。临床研究进一步表明,该酶活性与各种癌症类型患者的预后呈负相关。这些发现提示IDO-1抑制剂在恢复宿主抗肿瘤免疫力和减弱癌症转移方面可能发挥作用。来自IDO-1抑制剂的临床前和I/II期临床研究的数据支持这一假设。多酚作为抗氧化剂已显示出抗癌活性。然而,其潜在机制尚未完全阐明。我们最近发现,某些黄酮分子可显著抑制人神经干细胞(hNSC)中IDO-1的酶活性,但不影响其mRNA表达,这一结果通过基于细胞的试验和qRT-PCR得到证实。为了进一步研究,我们研究了其他抗癌植物化学物质,包括查耳酮、黄酮醇、异黄酮和二萜。在此我们总结结果并表明,抑制敏感性取决于分子结构,顺序如下:芹菜素>汉黄芩素>白杨素>双黄酮~染料木黄酮>槲皮素。姜黄素和异甘草素(一种查耳酮)对hNSC具有毒性。虽然冬凌草甲素(一种二萜)对hNSC无毒性,但与其在各种癌细胞系中的强细胞毒性相比,它对酶功能的抑制作用仅很微弱。虽然酶-多酚复合物的作用方式有待研究,但将酶抑制的敏感性与对三种癌细胞系的抗增殖活性进行了比较。从这两组实验中获得的IC50表明,它们处于微摩尔浓度附近,酶抑制作用稍强。这些结果表明,通过抑制IDO-1酶活性来减弱免疫抑制可能是多酚在化学预防或联合癌症治疗中的重要机制之一。